Investor's Business Daily on MSN
Hims launches oral Wegovy knockoff, but the FDA could prove to be a problem
Hims & Hers Health launched a compounded version of Novo Nordisk's already popular weight-loss pill on Thursday. The FDA ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...
Novo Nordisk share price plunges after blaming lower US drug prices, patent protection issues and rising competition ...
Shares in the Danish company which makes Ozempic and Wegovy plunged 18%, as its boss warned things would get worse before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results